Evidence map›Paper›PMID 21214190›Full record

ArticleAnalytical chemistry2011

Enhanced in vivo imaging of metabolically biotinylated cell surface reporters.

Johanna M Niers, John W Chen, Ralph Weissleder, Bakhos A Tannous

Open access · greenAbstract read
In one paragraph

Article in Analytical chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Single-molecule labeling for studying trafficking of renal transporters.American journal of physiology. Renal physiology · 2018
    Review
  9. Article
  10. Article
  11. Article
  12. Microvesicle-associated AAV vector as a novel gene delivery system.Molecular therapy : the journal of the American Society of Gene Therapy · 2012
    Article
  13. Single reporter for targeted multimodal in vivo imaging.Journal of the American Chemical Society · 2012
    Article
  14. Nanobody-coupled microbubbles as novel molecular tracer.Journal of controlled release : official journal of the Controlled Release Society · 2012
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Johanna M NiersNeuroscience Center, Department of Neurology, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA.
John W Chen
Ralph Weissleder
Bakhos A Tannous
Center for Systems Biology · USHarvard University · USMassachusetts General Hospital · US

Funding

StatisticsP50CA086355 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI WEISSLEDER, MD, PHD, RALPH · 2000 to 2015
$27.8M
Interdepartmental Neuroscience CenterP30NS045776 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI BREAKEFIELD, XANDRA OWENS, TANNOUS, BAKHOS A · 2003 to 2018
$11.1M
Glioblastoma stem cells therapyR01NS064983 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI TANNOUS, BAKHOS A · 2009 to 2019
$4.0M
Myeloperoxidase, imaging biomarker and treatment target for multiple sclerosisR01NS070835 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI CHEN, JOHN W · 2010 to 2014
$1.9M
Imaging and Treating Inflammation in Stroke by Targeting MyeloperoxidaseR01NS072167 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI CHEN, JOHN W · 2010 to 2014
$1.8M
Imaging and therapy of tumors using biotinylated cell surface docking sitesR00CA126839 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI TANNOUS, BAKHOS A · 2009 to 2011
$732k
Molecular imaging of vascular pathologyK08HL081170 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI CHEN, JOHN W · 2006 to 2010
$666k
Imaging and therapy of tumors using biotinylated cell surface docking sitesK99CA126839 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI TANNOUS, BAKHOS A · 2007 to 2008
$283k
NCI NIH HHS 4R00CA126839NCI NIH HHS K99 CA126839NCI NIH HHS P50 CA086355NCI NIH HHS P50CA86355NCI NIH HHS R00 CA126839NHLBI NIH HHS K08HL081170NINDS NIH HHS P30 NS045776NINDS NIH HHS P30NS045776NINDS NIH HHS R01 NS064983NINDS NIH HHS R01 NS070835NINDS NIH HHS R01 NS072167
6 · The paper itself

Abstract

Metabolic biotinylation of intracellular and secreted proteins as well as surface receptors in mammalian cells provides a versatile way to monitor gene expression; to purify and target viral vectors; to monitor cell and tumor distribution in real time in vivo; to label cells for isolation; and to tag proteins for purification, localization, and trafficking. Here, we show that metabolic biotinylation of proteins fused to the bacterial biotin acceptor peptides (BAP) varies among different mammalian cell types and can be enhanced by over 10-fold upon overexpression of the bacterial biotin ligase directed to the same cellular compartment as the fusion protein. We also show that in vivo imaging of metabolically biotinylated cell surface receptors using streptavidin conjugates is significantly enhanced upon coexpression of bacterial biotin ligase in the secretory pathway. These findings have practical applications in designing more efficient targeting and imaging strategies.

Indexed as

AnimalsBiotinCarbon-Nitrogen LigasesCell LineHumansMembrane ProteinsMiceBiotinCarbon-Nitrogen LigasesMembrane Proteins

Identifiers

PMID21214190
PMCPMC3059349
OpenAlexW1990604281

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.